UK markets open in 2 hours 45 minutes

Amneal Pharmaceuticals, Inc. (2DT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
5.55+0.15 (+2.78%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,393,607
2,393,607
2,212,304
2,093,669
1,992,523
Cost of revenue
1,573,042
1,573,042
1,427,596
1,324,696
1,364,130
Gross profit
820,565
820,565
784,708
768,973
628,393
Operating expenses
Research development
167,778
167,778
200,046
209,563
190,585
Selling general and administrative
429,675
429,675
399,700
365,504
326,727
Total operating expenses
596,315
596,315
595,786
575,067
517,312
Operating income or loss
224,250
224,250
188,922
193,906
111,081
Interest expense
210,629
210,629
158,377
136,325
145,998
Total other income/expenses net
-13,086
-13,086
-278,381
-26,215
-863
Income before tax
-40,270
-40,270
-248,127
31,366
-35,780
Income tax expense
8,452
8,452
6,662
11,196
-104,358
Income from continuing operations
-48,722
-48,722
-254,789
20,170
68,578
Net income
-83,993
-83,993
-129,986
10,624
91,059
Net income available to common shareholders
-83,993
-83,993
-129,986
10,624
91,059
Basic EPS
0.07
-0.48
-0.86
0.07
0.62
Diluted EPS
0.06
-0.48
-0.86
0.07
0.61
Basic average shares
152,893
176,136
150,944
148,922
147,443
Diluted average shares
155,083
176,136
150,944
151,821
148,913